ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000947.1|Vibrioferrin_1 # 154 # 1356 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.500	BGC0000947.1|Vibrioferrin_1 	154	1356	-	Loose	1300	28.4906	vanTE	33.33	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTCTAATTCCCTCTCTCTACCGACACTCGTTTGCCAACAAGTTCACACACTCGCACAGCAGCAAAGTCAACCCTTGTGCGCATACGTGTATGACCTAAGCGCCTTAGAAGAACACATCAAACAACTGCGTCACGTTTTGCCGAGAAATGTCGAGCTATTTTACGCAGCCAAAGCCAATCCATCGGGCCCGATTCTTAAAACGCTCGCGCCGTATGTCGATGGTTTTGAAGCGGCATCTGGCGGGGAGTTGACACACCTCCACCAGCAACAACTCGATAAGCCATTGATCTTCGGTGGCCCCGGAAAAATGCTAAGTGAATTGCAACAAGCGATTGAGCTTGATGTTGATGCATTTCATGTCGAAAGCCTCACCGAGCTACAACGCATTGGAGCACTAACCGAGCGCCTCAACCGCCCTGCTTCGATCTTTTTGCGTATGAACATCGATATTGGCGACATCACGCTCAGCAAGTTGGCGATGGGTGGCAAGCCGACTCCATTTGGCTTGGACGAGTCCGAGCTGAGTAATGCTTTGATGTTGCTGCGCGATTTCCCGCAAGTGTCACTCAAAGGCTTCCATTTTCACTTGATGTCGCATCAGCTCGATGTTGAACGTCACTTAGCGTTAATGCAGCGCTATTTCCAAGTCGTGAAAACGTGGCAGCAGGAGTTCAAACTCAGTGAGCTGATGATCAACTTGGGCGGCGGTATGGGGATTAACTACCAAAACCCTGAGCAACACTTTCCGTGGATGGAGTTTTGCGACAAGTTGGAATTCCTCATCGCCAAAGAGCAAGTGCAAGACTGGACACTGCGTTTTGAATGCGGACGTTTCATCACGGCGGCATGCGGTTATTACGTGATGGAAGTACTGGATATTAAACAAAATCTTGGCGAAAACTTTGTCATCGCGCGCGGAGGAACTCACCACTTCCGCACGCCAGCGGCGCAGAGCCATGATCATCCATTCGTCATCCTGAAAAGCGAGCAACACCATGAGATTTCTCATCCAATTCAGCATGCACAAGCGACCTTTGTCGGCCAGCTTTGTACGCCCAAAGATGTGCTGGCACGCAATCAACACGTCGCCCACGTCGATATTGGTGATTACGTTGTGTTTACCTTAGCGGGCGCCTATGCGTGGAACATCTCCCATCAAAACTTCTTGATGCATGAACCGCCGATCTTCCACTATTTTTAA	MSNSLSLPTLVCQQVHTLAQQQSQPLCAYVYDLSALEEHIKQLRHVLPRNVELFYAAKANPSGPILKTLAPYVDGFEAASGGELTHLHQQQLDKPLIFGGPGKMLSELQQAIELDVDAFHVESLTELQRIGALTERLNRPASIFLRMNIDIGDITLSKLAMGGKPTPFGLDESELSNALMLLRDFPQVSLKGFHFHLMSHQLDVERHLALMQRYFQVVKTWQQEFKLSELMINLGGGMGINYQNPEQHFPWMEFCDKLEFLIAKEQVQDWTLRFECGRFITAACGYYVMEVLDIKQNLGENFVIARGGTHHFRTPAAQSHDHPFVILKSEQHHEISHPIQHAQATFVGQLCTPKDVLARNQHVAHVDIGDYVVFTLAGAYAWNISHQNFLMHEPPIFHYF	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	56.98	gnl|BL_ORD_ID|1234|hsp_num:0	1308		
BGC0000947.1|Vibrioferrin_2 # 1349 # 3091 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.495	BGC0000947.1|Vibrioferrin_2 	1349	3091	-	Loose	450	27.335	Chryseobacterium meningosepticum BlaB	23.08	3000579	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGGGTGTTCTTAATTGTTACTTACGTGAATTTGCGCTACCGAATCAACAAGTGGAATGGCACTACCAATCGACATCGCTACCCCAAACGTTAAAACGCAACTATCCCGCTAAACAGCGGATAGCCGTTCATCTTTCTCAACAAAATGGCGTGCTGGTTTTGCCGATTCACTACGCGAGCAAACTGGGCAAAATCAAATTGGCAGAACTGCCTTGGGCGAAAATGCCGGGATCTGGTTGGGCGAAATTGGATGCCACGCAAACTCTTACGCTTTTGCTTAACTATCTCAAGCAGGTATTGGCGATCCCGTTTAACCATGAGCTGATCGAACAACTAGAAAATAGCGTGCTGGTTACCGAGCAGTTTCTCAACGTCGCGCCCAAATCGCATCACAACGAATTTATCGCTTCGGAACAATCTCTGATTTGGGGGCATACTTTCCATCCGACCCCGAAAAGTCGTTCGGGCGTCACCATGGATGATCTCTTGGCGTTTTCTCCAGAAGTCGGCGCGCAAGTCCCGTTGTACTGGTTTGAAGTGGATACGTCCTTACTTGATGTGCTGAGTTCCGACGGAGAAGCTAACCCTGCGCAGCGCATGCTACAACGGCTCGCGGCACAACACGCCACCAGCAATGGGAAGACCCTCTACCCTTGTCATCCTTGGGAAGGCTACACCATTTTGAGTAACCCAAGCGTGAAGCGCGCCATTGAACAAGGCAAGATCACGCCACTGGGTTTAGGTGGTGAAAAGATGCAGCCGACCTCTTCAGTTCGTACCCTCTACCACCCTGACATGGACTGGTTTGCGAAATTCTCCATCAACGTACGATTAACCAATTGCGTGCGCAAAAACGCGTGGTACGAACTCGACAGCGCCGTGCAACTCACGTCGATTCTCAAACCAATTAGAGAAAACGAACAGCTGCACAACCCCGTATTTAAAGTGATGACAGAGCCTTACGCCACCACGTTGAATCTAGAAAGTGTCGCTGAGCACAACTGGGACGACAACACCAAAGCACGCGAATCGTTTGGGATTTTGTATCGCGAAAATTTCTCGCTGAGCGAAGTCGACATCTTGAAACCAACCCTCGCTGGCGCTCTGTTTGCTTACGATAATAACGGCAACAGTCGCATTGCTCAACGCCTTAAAAACAAAGCGCGTACTACGCAAAGTCGCTATTCCGACATCGCGACACTTTGGTTTGAACGCTATTTGCATTGCCTGATCCCGGGCGTATTTAATTACTACTTCAAACACGGGGTGGCGTTTGAGCCGCATTTGCAAAACACCCTGATTGGCTTTGAGCAAGAGATGCCGTGTTGTGTTTGGATTCGTGATTTGGAAGGCACCAAGTTACTGCCGGAGTTCTGGCCAGCAGAAACTTTAACTGACTTGTCTGAACGCGCGCGACAATCGGTTTACTACAGTCGCGAACATGGCTGGAATCGCATCGGATACTGCACCTTTATCAACAACATCAGCGAAGCGATTTTCTTCATCGCAGAAGGTGACGAGCCACTAGAGCAAACGCTATGGAATGCGGTGCAAAGTGCCATTGTGCGTTGGCAATCAGTGAATGGAAAACAGCCGGAACTAGAAGCGTTGCTGAATGGCGGTCACTTCCCGAGCAAAAATAATTTCACCACGCGTTTGATGCAAAAAGCCGATAAGGAGTCGGGCTATACCCAAGTCGCCACGCCTTGGCAGCAACACGAAAAAGGAGCGCAACATGTCTAA	MGVLNCYLREFALPNQQVEWHYQSTSLPQTLKRNYPAKQRIAVHLSQQNGVLVLPIHYASKLGKIKLAELPWAKMPGSGWAKLDATQTLTLLLNYLKQVLAIPFNHELIEQLENSVLVTEQFLNVAPKSHHNEFIASEQSLIWGHTFHPTPKSRSGVTMDDLLAFSPEVGAQVPLYWFEVDTSLLDVLSSDGEANPAQRMLQRLAAQHATSNGKTLYPCHPWEGYTILSNPSVKRAIEQGKITPLGLGGEKMQPTSSVRTLYHPDMDWFAKFSINVRLTNCVRKNAWYELDSAVQLTSILKPIRENEQLHNPVFKVMTEPYATTLNLESVAEHNWDDNTKARESFGILYRENFSLSEVDILKPTLAGALFAYDNNGNSRIAQRLKNKARTTQSRYSDIATLWFERYLHCLIPGVFNYYFKHGVAFEPHLQNTLIGFEQEMPCCVWIRDLEGTKLLPEFWPAETLTDLSERARQSVYYSREHGWNRIGYCTFINNISEAIFFIAEGDEPLEQTLWNAVQSAIVRWQSVNGKQPELEALLNGGHFPSKNNFTTRLMQKADKESGYTQVATPWQQHEKGAQHV	MLKKIKISLILALGLTSLKAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTDKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINEYQQKQKASN	232.93	gnl|BL_ORD_ID|2563|hsp_num:0	237		
BGC0000947.1|Vibrioferrin_3 # 3091 # 4356 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.508	BGC0000947.1|Vibrioferrin_3 	3091	4356	-	Loose	700	65.855	mdtG	23.87	3001329	protein homolog model	n/a	n/a	fosfomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCAAACTCATCTACAGCGTGTTGTTGTGCCACTTTATCGCTGCGTTTGCCGCGTTAGGTATGCCGCTATTTCTACCCGTCGTGTTGCCAACGTTAGGCGCAAGCATTGATGCAGACTGGGCAGGGGTATTGTTTATCCTACCCACGTTTTGTACTGCGTTGGCGGCGCGATTTTGGGGCAACTTTGCTGATCGCTACGGTCGCCGCCGCTCACTCTTGCGCGCGCAACTTGGCCTTGCAGCAGGGTTTGCGCTGTGCGGCTTTGCAGACAACCTCGCCATGTTTGTGTTTGGTCTTATTGTTCAAGGAACCTTTGGCGGCACCATGGCCGCCTCGAACAGCTACTTATCTAGTCAAATTAAAGAAGCCAAAACACTCGGCAAGTCACTCAATAAAACCCAGCTATCTGCTCGCTTGGCGCTGATCGTTGCGCCTATTGGGCTCGGCTGGAGCTTGTCAGAGACCAACCCGCTCAACGCGTACCTTTGGTTATGCGTTTTGCCTTTGATTGCGATGGGCATCACGCTAACACTGCCAGTGGATAAACCCGCCGACCAAAACCTCGAAAAGCCAAACTCAGAACCTCAGCAAGAAAAACCGGTTGCACAGAAAAACGCAATGCATGCCATTCGTTGGATCTTCTTTGCTCAGTTCGGGTTTGCGTTTTCTATGGTGGTGACCTTTCCTTATTTCTCGCCGTTTGTGCAGCAATATGGCATCACTAACCACGCATGGATCGGTTTTTTGTACGCACTGCCGCATGGTGTCTATCTGTTGCTGGCAGGCAAAATCCACGTGTTGTCAGATGGGCTGAATCGGCATCAACCGCTGCGCACGTTGTGGCTTGGGTTTGCATTGCTTGCCGTGAGCTCTGCCTTGCATTTGATTGCATCCGAAACCGCACTCATTGCTGCGAGAATTATCTTCGGCATCGCGATGGTGTGTTGTTATCACGGATTGCATCAGCATCTTGCGAGCAATCTGGATCGCAAACTCAGTGGCAAAGTATTTTCTCGCTTTGATGCCATGTCCAAATGGGGGGGCGTGGCAGCGGGATTTTGCGCTTCTTTCATTTCTAGCTTGGGGCTACTTGAGGTTCCTTTCCTACTTTCTGCGATAGTCAGCGTAATCACCTTGATCGCGCTGGTTCTCCACTTCAAAATTTGGAAATCAACATGTTACAAACTCAATCCTCTCAGACTAGCGAGTTGCGCGCGCATGAGGTGCAGCTCAACCGTGAGAAAGCCCAACTCAACACGATAA	MTKLIYSVLLCHFIAAFAALGMPLFLPVVLPTLGASIDADWAGVLFILPTFCTALAARFWGNFADRYGRRRSLLRAQLGLAAGFALCGFADNLAMFVFGLIVQGTFGGTMAASNSYLSSQIKEAKTLGKSLNKTQLSARLALIVAPIGLGWSLSETNPLNAYLWLCVLPLIAMGITLTLPVDKPADQNLEKPNSEPQQEKPVAQKNAMHAIRWIFFAQFGFAFSMVVTFPYFSPFVQQYGITNHAWIGFLYALPHGVYLLLAGKIHVLSDGLNRHQPLRTLWLGFALLAVSSALHLIASETALIAARIIFGIAMVCCYHGLHQHLASNLDRKLSGKVFSRFDAMSKWGGVAAGFCASFISSLGLLEVPFLLSAIVSVITLIALVLHFKIWKSTCYKLNPLRLASCARMRCSSTVRKPNSTR	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	103.19	gnl|BL_ORD_ID|564|hsp_num:0	603		
BGC0000947.1|Vibrioferrin_4 # 4363 # 4719 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.485	BGC0000947.1|Vibrioferrin_4 	4363	4719	-	Loose	875	24.2534	mdtP	29.23	3003550	protein homolog model	n/a	n/a	nucleoside antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTACCACCATCACATTACAACTGGATATCGCAGCGATTGTAGAAGCCATGGCAGCGAAGGGCATTGCCTCTTCAGCATCGCTTTACGCCATCGTGGCCAAAAGCATTGCAGAGCAACTCAACCGACTAGAAAGCGGAGGGTTAGAGACAAAACTGGCACGCGAGTTACTGCAAGAAGCACCTGATTTGTACGCCAAATACTTGTTGAGCTCTGGCAGTTTGCTCTCGAAAGAAGCCTCCGGCGCGAGTGACATCAATAAGTTCTATGGTTTGTCGGCTCCGAACTTCTTGCTGCTTTCTAGCAAAGAAGCGCAACGCGCCTACTTAGAAGCCATCAAAAAAAGCGTACGTTAA	MFTTITLQLDIAAIVEAMAAKGIASSASLYAIVAKSIAEQLNRLESGGLETKLARELLQEAPDLYAKYLLSSGSLLSKEASGASDINKFYGLSAPNFLLLSSKEAQRAYLEAIKKSVR	MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAGPVVEKK	24.18	gnl|BL_ORD_ID|36|hsp_num:0	45		
BGC0000947.1|Vibrioferrin_5 # 4674 # 6194 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.494	BGC0000947.1|Vibrioferrin_5 	4674	6194	-	Loose	1000	28.4906	MCR-9.1	35.29	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAATGACAACGCTTTGTATCTAACGCAACGATTGATCGACACTTGCTTACGCGAAGACATGTTTGGCATTTTGTCGAAGGCCAAGTTCAGTAGAGACGCGCCAAAAGGGGTAATTGTTCCTCAAGACGAGCAAGTCTGGCTGATATTTGCCAACTCTGATTTCACGTTGTATTTACCTGTTGCGCCAGCGTATTACATGCAGCACTGGCGCTACGGTCACGCCAATGACGAAACACCACCAGGTTGGTGGGTGGAGAAAAATGGCCAAATCGAGCATCAACAGCATTACAAAGAGTGGATTGCGCTACTAACGACACTGGCGCATGAGAGCTCTCACGAGTTGCTGGCGGGATACCTTCAAGAACTGGAATGTGCAGAGAAACACAAAGCGCTGTGTGACCAAGCGTTTCATCATCACGCAGACCACATTTCTCAACCAATATCCAAGCTTGGTTCTTGGCATCAAAAACTGCTGCTAGCCGACCAGATCGCTTCTTACCTTGACCACCCGTACTATCCAACTGCGCGGGCGAAGTTTGGCCTGAGCGATGAAGACCTTGCTAAGTACGCGCCCGAGTTCGCACAAAGCTTTGCTCTGCATTGGATTGCGATTGAAAAATCACTGTTGACATTAACTAGCGAACAACCTGATTGCTGGCCAACCATGGAGCAAGTTGGGCTTCCTGCTGATTTTGCACTGAGCCACGTACTGTTCCCTGCGCATCCGCTCACCCTGCGATCTTTAGAAGCCTTACCCGAAGGTATGATAGAAGCGCCTTTAACGTATCTAGACGTGACGCCGACGCTTTCCGTTCGTACGGTGGTCGTGAACGACGCACCGCACATTCACATCAAGGTTCCGCTGATCATGCGATCGCTAGGCACGAAAAATATTCGCTTAATCAAGCCTTCAACACTGTATGACGGCCACTGGTTTGAACGCCTACTCAGCCACCTTGAACAAACGGACGCCGATTTAAACAGTCGCTTGTTCCATTGCAACGAAAAACACGGTGGACACGTCGGCGAGGATAAAACCTTCGCGTACATCGTACGTGAGTATCCACTTACTCATTGCGAAGACAAAGCGTTAGTTCCGGTTGCAGCACTAGCAAGCCCAATGCCTGACGACCGCTTGTTCTTAGAACATTTGGCAGAACATTACTATCAACAAGATACGCTGGCGTGGTTCCAAGATTACGTCGATCTATTATGCCAAGTGCACCTCACCTTGTGGCTTCGTTATGGCATCGCATTGGAGTCCAACCAGCAAAACGCCATCATTGCATTTGATCAACAGGGCAAAATGACGCTCGCGATGAAAGACAACGACGCGGCGGAATTTGGCCAGAGCGCTTCCACTTTGCAACAGAGCATGCTGCCCAAAAACACGGCGCAAAACTACTTCCAGTGGATTGCGATGAACTGCTCGATCAACGCATCAAAGTCGACAATGAATTGGCGCTCGGTCAGATGTTTACCACCATCACATTACAACTGGATATCGCAGCGATTGTAG	MNDNALYLTQRLIDTCLREDMFGILSKAKFSRDAPKGVIVPQDEQVWLIFANSDFTLYLPVAPAYYMQHWRYGHANDETPPGWWVEKNGQIEHQQHYKEWIALLTTLAHESSHELLAGYLQELECAEKHKALCDQAFHHHADHISQPISKLGSWHQKLLLADQIASYLDHPYYPTARAKFGLSDEDLAKYAPEFAQSFALHWIAIEKSLLTLTSEQPDCWPTMEQVGLPADFALSHVLFPAHPLTLRSLEALPEGMIEAPLTYLDVTPTLSVRTVVVNDAPHIHIKVPLIMRSLGTKNIRLIKPSTLYDGHWFERLLSHLEQTDADLNSRLFHCNEKHGGHVGEDKTFAYIVREYPLTHCEDKALVPVAALASPMPDDRLFLEHLAEHYYQQDTLAWFQDYVDLLCQVHLTLWLRYGIALESNQQNAIIAFDQQGKMTLAMKDNDAAEFGQSASTLQQSMLPKNTAQNYFQWIAMNCSINASKSTMNWRSVRCLPPSHYNWISQRL	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	93.88	gnl|BL_ORD_ID|2301|hsp_num:0	3383		
BGC0000947.1|Vibrioferrin_6 # 6191 # 7402 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.484	BGC0000947.1|Vibrioferrin_6 	6191	7402	-	Loose	650	44.2838	vanF	29.73	3002908	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGAAATCTACGATGATTATCGTAAGTCATGTCGTTAACGATGCAGTCACTCACGGCTTAGTGCCTGCAGCTAAAGCGATGGACCTTCACGTCGTTCTTATCACCGACCATAAGCTCAGCCATTTAGAGTTGGCGAGTCGTGATAGTCACTTTAATCCGGATACCATTCTAGAATGTGATGTCTTCAACCCATTAGAACTCATCGAAACCATCACGGAGCATGAATTAAAGCCAGACGCTATTTTCAGCAATAGTGATCACTTACAAACTTCCACCGCCATCTGCGCGCAATTTTTTGGCCTCCCATCCAAAGATTGGTCTGTCACGTTAAAGGCCAAAAACAAACACTTAACTCGACAAGTGTTAAATGAAAAATCCTTACCCAACACACAAAGCTGTTTGCTGCATCGCCATTCGAATGTGGCATTAGGCATGGCCTTCCCTGTCGTAGCAAAACCCAAAGAAGGCGTGGCAAGTCTAGATGTACAGCGCTGTGACTCCCAAAGCGAGCTCGATGCTTACTGCGAGGCGTTTTGGCAAAAGCACCCAAACGCCGCCATTCTGGTGGAGCAGTTTCTTCAAGGACCTGTGGTTACGCTCGAAACTTTAGGAGACGGTAACCAACTTATCGCCGTGGGCGGTTTTGATGTGTCGCTCTCTGAGCCGCCTTACTTTATCGAAACCGCCGCAGACTGGAACGGACCAAACGGCATTGCTCACCGAGAAGCTTGCTTGGCTCAACTGAAAGCGTTCGGCGTTGGTTTTGGAGTTTGCCACAGCGAATTTATCATCACGGAAAACGGCCCAGTTCTGGTGGAAATCAACTACCGCAGTATTGGAGATGGCCGCGAATTCTTGCTCAACAATCTCGCTCACTTTGGTTGGTTTAGCACAATTTTGGGTCTGCATTTGGGTCGAAGATTGGACGGCGATTACCAAATTCATGGGTCAGCGCACGTGCACTACGTAGTTGCGGAACACAGCGGTGTGATCGACGGAGGTTCGACGTCGTTCATCCAACACGATGACGATATCATCACTCAGCAACAGGTACTAAAAACCGCTGGAGAACACTTCCAACAGAGTTATTCCAATAAGGATTATCTCGCCCGAATTTCGATTGTCTCACCATCAGGGCGAAACCTCGACCAATCGCTGCAGAACGCGCTTAGCAATTTCAATCTAGCTCCGACTCGTGAGGTGGCAGCATGA	MKSTMIIVSHVVNDAVTHGLVPAAKAMDLHVVLITDHKLSHLELASRDSHFNPDTILECDVFNPLELIETITEHELKPDAIFSNSDHLQTSTAICAQFFGLPSKDWSVTLKAKNKHLTRQVLNEKSLPNTQSCLLHRHSNVALGMAFPVVAKPKEGVASLDVQRCDSQSELDAYCEAFWQKHPNAAILVEQFLQGPVVTLETLGDGNQLIAVGGFDVSLSEPPYFIETAADWNGPNGIAHREACLAQLKAFGVGFGVCHSEFIITENGPVLVEINYRSIGDGREFLLNNLAHFGWFSTILGLHLGRRLDGDYQIHGSAHVHYVVAEHSGVIDGGSTSFIQHDDDIITQQQVLKTAGEHFQQSYSNKDYLARISIVSPSGRNLDQSLQNALSNFNLAPTREVAA	MNRLKIAILFGGCSEEHDVSVKSAKEIANNIDTEKYEPIYIGITRSGVWKMCEKPCMDWDNENCRSAVLSPDKKMHGLLVMRNKGYQIQRIDAVFSVLHGKSGEDGAIQGLFELSSIPYVGCDVQSSAVCMDKSLTYIVAQNAGFGTPEFLILNHGDIPDSNTLTYPVFVKPARSGSSFGVNKVNNEDELDAAIETARQYDSKVLIEQAVPGLEVGCAVLGNGTDLIVGEVDQISLSHGIFRIHQEDQPEKGSENAVVLVPANLSAEKRIKIQETAKAIYKALGCKGLSRVDMFLQENGRIILNEVNTLPGFTAYSRYPRMMAAAGMTLSGLIDHCITLALKG	117.49	gnl|BL_ORD_ID|1658|hsp_num:0	1759		
BGC0000947.1|Vibrioferrin_7 # 7653 # 9431 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.483	BGC0000947.1|Vibrioferrin_7 	7653	9431	+	Loose	500	28.8758	MSI-OXA	32.31	3003719	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI-OXA family beta-lactamase	ATGAATAAATTATTGACCCTGACCCCCTTGGCGGTCGCGATTGGTTCTTCATTAGTAGCACCAAGCGCAGTGGCTTCAGAAGAGACGAACTCAACCCCATCAGCAACTGAAACGATTCAAGTCTTCGGTCATCAGTACGAAGGTTATGCTGAACACATGCCTCAATCTGGCACCAAAACCGATGTGGAATGGCTTGATGTGCCACAAGCGGTATCCGTAGTAACGAAAACAGAAATGCAAGACCGAGGCGCGGTGCGTTTAGTGGATGCGCTAGATGGGGTAGCCGGGGTCAATAACACCTTGGGCGAAGGCAGCCGCGATCAGTTCATGATCCGTGGTTTTGATTCACTCAACGATATGTACCGTGATGGCTTGCGAGATGACGGTACGTTGCAGTCTTACCGCAGCTTAGCGAACGTTGAACGCGTTGAAATTGTGAAAGGCCCTGCGGGTGCTTTGTATGGCCGTGGTTCGGCTGGGGGCATCATCAACTTGGTGACGAAACGCGCTAACGGTGAGAATTTTACTCACGTAAACGGTAGTGTAGGCAGCAACAACCAATATGTTGGTCAGGTCGACAGCTCAATGGCGTTTACAGATAAGGTCAACGGGCGTATTAACTTGGAATACCGTCAAGCCGACTCGTACGTTGATCATGTTGATTCAAACGATTTCTTCATTGCACCGACCATTCGTGTGTTACCAGCGGAAGGTCACACCATTGATATTGACGTGGAATACGCCCATCAAGAACTAGTGCCGTATCGTGGTGTGCCATCAAAAAATGGCAAGCCAGTTGATTTGCCAGTAAGCACTTACTTTGGCGGCACAAACGACTATCAGGAGTCAGACAGTCTCCGTATTGCGGTGGATTACGAATGGCGTCTGAATGATCAATGGGTATGGAACAACCGAGCGGCGTTCAACCATATCGAACTTGAGCAAAAAGGCACGCGTCAGGGCAAAGTGACGGGTAATGAAGTGTCTCAAACCGTCAACAACTTTGGTTACGATCCACGTACTACGACCACTTTACAATCTGAGTTGGTTTGGGAAACCAGGGACAATCAATTGATGGTGGGTGCAGATTTCAACCAGATCGATATCGACCTAACGTTGGCAAGTGACAAAACGCTTCCTCCGCAAAATATCTACGACCCAGTCGTTGGTCCAACGCCTGATCCGGGCTTTAAGCCATTTCGTGACAATACCACCACCACGACAGGTTTGTATGTGCAAGACGTCTATACGTGGGGTGACCTTTCTTTGATCGGTAACGTGCGTTACGACTCGATGGAACTCGAACAACAAAAAGCGGGCTCAGATAAGGAAAAATTGGATGATGACAAAGTCAGCTACCGTGCTGGTTTGGTATACCGCATCAATTCCGACACATCCGTATACGCCAGTTTAGCGCGCTCTTGGCAGTTACCGTACGCTGGTATCTACATCAATCCAAAATTGGCGGAATTCTTCCACACCGACTTAAAAGAGGTGGGTGCGAAAGCGTACCTTTTGGATAACGCATTAATGTTGAATGCGGCACTGTTCCAGATTGATCAAGAGCAACCACAAACTAACGTGGACGGCGATGTGATCGATAAAATTGAAGTGCGTCACCAAGGTATTGAATTAGAGGCTCGCGGTCAAATCACCAAACAGTGGGACATCTCTGTGGGTTACAGCTACTTGGACGCGGAAGACAAAGCCACAGGCAAAAAGCCGAACGATGTATCAGACCACTTGTTCTCTCTTTGGAGCACTTACCAATTTGGATGA	MNKLLTLTPLAVAIGSSLVAPSAVASEETNSTPSATETIQVFGHQYEGYAEHMPQSGTKTDVEWLDVPQAVSVVTKTEMQDRGAVRLVDALDGVAGVNNTLGEGSRDQFMIRGFDSLNDMYRDGLRDDGTLQSYRSLANVERVEIVKGPAGALYGRGSAGGIINLVTKRANGENFTHVNGSVGSNNQYVGQVDSSMAFTDKVNGRINLEYRQADSYVDHVDSNDFFIAPTIRVLPAEGHTIDIDVEYAHQELVPYRGVPSKNGKPVDLPVSTYFGGTNDYQESDSLRIAVDYEWRLNDQWVWNNRAAFNHIELEQKGTRQGKVTGNEVSQTVNNFGYDPRTTTTLQSELVWETRDNQLMVGADFNQIDIDLTLASDKTLPPQNIYDPVVGPTPDPGFKPFRDNTTTTTGLYVQDVYTWGDLSLIGNVRYDSMELEQQKAGSDKEKLDDDKVSYRAGLVYRINSDTSVYASLARSWQLPYAGIYINPKLAEFFHTDLKEVGAKAYLLDNALMLNAALFQIDQEQPQTNVDGDVIDKIEVRHQGIELEARGQITKQWDISVGYSYLDAEDKATGKKPNDVSDHLFSLWSTYQFG	MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL	217.65	gnl|BL_ORD_ID|2077|hsp_num:0	2234		
BGC0000947.1|Vibrioferrin_8 # 9382 # 9690 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.495	BGC0000947.1|Vibrioferrin_8 	9382	9690	+	Loose	500	25.409	OXA-258	18.52	3001503	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTATCAGACCACTTGTTCTCTCTTTGGAGCACTTACCAATTTGGATGACAACTGGCGTTTAGGCGGTGGTGTGAAGTACGTGGGCGACCGTTACGCAGGTAACGACGAAGCTGTCGCACTTGGCGATTACACAACGGTGGATTTGATGGCGGCGTACACCACTGGTCGTCATAAAATCCAAGCGAACGCTTACAACATTTTGGATGAGAAATACATTCTTGGCGCAACAAACGGCACGTCTGGCTTAAACCAGATTGGCTACGGCGCACCAGCCGAGTTTATGCTCAGCTACGGATATCAGTTCTAG	MYQTTCSLFGALTNLDDNWRLGGGVKYVGDRYAGNDEAVALGDYTTVDLMAAYTTGRHKIQANAYNILDEKYILGATNGTSGLNQIGYGAPAEFMLSYGYQF	MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFARLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK	37.23	gnl|BL_ORD_ID|1565|hsp_num:0	1659		
BGC0000947.1|Vibrioferrin_9 # 9813 # 11951 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.491	BGC0000947.1|Vibrioferrin_9 	9813	11951	+	Loose	700	30.4166	Escherichia coli ampC beta-lactamase	33.85	3004290	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGTCTTACCAGAATTTGGATGGTAAAGTGCGTGTACGTGCTGGTTTGTCTACCACTTACAGTGTGCTTGCGATTGCAATCGCTTCTGCCACATCCATGAGCGCGGTTGCCGCTCCTGCTAAAACAGAACAAACTACCGCGATGGAAACCGTCGTTGTCACTGGTAGCGTGATTGGTAAATCTGAAATTGAAGACGTCAAAGAGTACCCAGGTGCTCGTACCGTCATTACCCGCGAGCAAATCGAGAAAACCGCCGCAGGCTCGATTGATAACGCGCTACAGCGCGTGCCGGGTATTAAAGTTCAGGATGAAAGCGGAACGGGCGTATTGCCCAACATTTCCGTACGTGGTTTGAAAGCAAGCCGTAGTGGTCATGCTCAGTTCTTGATGGATGGTGTACCGCTAACACTTGCGCCATATGGTCACACTGGTCAGTCTATCTTCCCAGCAACACTGTCGATGCTTGATCGTATTGACATTGTACGCGGTGGTGCTGCAGTACAGTACGGCCCAAACAACGTCGGTGGTGTGATCAACTTAGTGACCAAACCGATTCCACACACGTGGCAAACTGAAATCAGTAACCGCCTTACCGTGTTTGATGGCGGTGATGCGCCGCTGAATGATTTTTACCTACGCACGGGCGGCTGGTTAAGCGACACATTTGCACTACAGTTGGAAGGTAACTTCCTAAAAGGTGAAAGCTTCCGTGAACATTCCGATACGGACGTGAAGAACTTTCAAGCTAAAGCACAGTGGCTATTGAGTGACACTCAAGAGATTCAAGCATTCCTGCAACGTTACGATGCTGAAACGCAAATGCCGGGCGCACTTTCGCCACAAGACTACGAACAAGATCGTCACCAATCGAAACGTCCTTACGATGATTATGAAGGTAAGTCGACACGCTGGAGTGTTAAGTACATCCACGATTTGCCATTTGCCGACAGTGCCGAGCTAGAAGTGCTAACGTTTGGCCATAAGTCAGAGCGTCTTTTCAAGTGGGGCTTTAACAGCGCGGGTGGCCATTGGGCGGATCCGGCTCTGCCAGCGACGGACGTTCGTACCTCTCCACGTGAATTTACCGTGTATGGTATAGAGCCAAAAATGGCGATGTACTTTGGCGAAGGTAAATCCGTTACTCAAAACTGGATCGTGGGTACCCGTTATGTTAATGAAGACATTGACTACAAACTCACTCAGACTCCAATCGCCGGTGGTGCAACCAGCGTTCCGCGTGATTGGCATCTAGATACGGACGCGTTTGCTGGATACGTTAGCAACGAAATTGGTTTGTTCAATGATACATTGAAGGTAACGCCTGGGTTGCGTGTTGAGTCGGTTCGAATGACGTTTACCGATCGTGTTAAAAAACAAACGGCAGACAACACCGTGACGGAATGGTTGCCAGGTTTGACGGTGGCATACAACTTAACTGACCAGTGGGTGACGTATGCGAACGCGCAAAAATCACTTCGTGCGCCACAAATTGCCTACATCCGAGGTTTGGGTGAAGAAGGTAGTGAACTGGCTTGGAACTACGAAGTCGGCGCGCGTTACACCCAAGATGCGACCAGCTTTAACGCTGCACTTTATCGCATCGACTTTGAAGATCAATTGCAATGGCAAAGCTCAACGCAGACCTTCGATAACATCGGAAAAACACTTCACCAAGGCATAGAGCTTTCTGCTCGTTACGTGCCTGAAGCACTACCTGCACTGAGTTTAGGCGCAAGCTACAACTATCTAGACGCTACGCTTGAAGAAGAAGGCGCGAATAAAGGTAATCAACTGCCTTACACCTCTAAGCATCAGCTTGGTTGGGATGCAACCTACGCATTTTACGGCATGGACACCACGCTATCGGGCTTCTACTTTAGTGATTCGTATACCGATAACGCCAACACCAGTGCCGAAGATGCAACTGGCGCAACGGGTAAAGTACCATCTTACATGGTGTGGAACTTCAACTTGGGGACGGATTTATACAAAGACGACAAAGGCAAGTTACGCATGAATGTTGCGGTGAACAACTTGTTTGACGAGGAGTATTACTTCCGCGGGATTGATACAAGCCCAGTTGGTCGGTACCCAGCTCCGGGACGCTCTTACACACTGGATCTGAACTATCAGTTTTAA	MSYQNLDGKVRVRAGLSTTYSVLAIAIASATSMSAVAAPAKTEQTTAMETVVVTGSVIGKSEIEDVKEYPGARTVITREQIEKTAAGSIDNALQRVPGIKVQDESGTGVLPNISVRGLKASRSGHAQFLMDGVPLTLAPYGHTGQSIFPATLSMLDRIDIVRGGAAVQYGPNNVGGVINLVTKPIPHTWQTEISNRLTVFDGGDAPLNDFYLRTGGWLSDTFALQLEGNFLKGESFREHSDTDVKNFQAKAQWLLSDTQEIQAFLQRYDAETQMPGALSPQDYEQDRHQSKRPYDDYEGKSTRWSVKYIHDLPFADSAELEVLTFGHKSERLFKWGFNSAGGHWADPALPATDVRTSPREFTVYGIEPKMAMYFGEGKSVTQNWIVGTRYVNEDIDYKLTQTPIAGGATSVPRDWHLDTDAFAGYVSNEIGLFNDTLKVTPGLRVESVRMTFTDRVKKQTADNTVTEWLPGLTVAYNLTDQWVTYANAQKSLRAPQIAYIRGLGEEGSELAWNYEVGARYTQDATSFNAALYRIDFEDQLQWQSSTQTFDNIGKTLHQGIELSARYVPEALPALSLGASYNYLDATLEEEGANKGNQLPYTSKHQLGWDATYAFYGMDTTLSGFYFSDSYTDNANTSAEDATGATGKVPSYMVWNFNLGTDLYKDDKGKLRMNVAVNNLFDEEYYFRGIDTSPVGRYPAPGRSYTLDLNYQF	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ	188.86	gnl|BL_ORD_ID|2497|hsp_num:0	2843		
BGC0000947.1|Vibrioferrin_10 # 12052 # 12975 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.469	BGC0000947.1|Vibrioferrin_10 	12052	12975	+	Loose	950	24.6386	msrE	30.0	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGAAAAATAAAAAACAATTTACGATCAAACACTTTTCAACCGTTTTGCTGATGCTGTTGAGCTCAGCTTTGATGTCATTTAGCGCATTTTCTCAGGCGCGCAGCGTGCAAGATGAGCAAGGCACTTTTGAGCTAGAAGCGATACCTCAACGTATTGTGGTTTTAGAATTTTCGTTTGTCGATGCATTAGCGGCAGTCGATGTCTCACCTGTAGGCGTCGCCGATGACAACGATGCCATACGAGTCATCCCTGCTGTTCGTGCCAAGATTGAACCTTGGCAATCGGTCGGCATGCGCTCACAACCGAGTTTAGAGGCGATTGCGGTGCTCAAGCCGGATTTGATCATTGCCGATGCCGAACGTCATCGCGCGATTTATCAAGATTTGCAGCGAATTGCGCCAACTTTGCTGTTAAAAAGCCGTGGAGAGACATATCAAGAAAATCTCGAATCCGCACAAAAAATCGGCGTGGCAATTGGCAAGCAAGCGAAAATGACACAACGAATTGAGCAGCACAAACAGACAATGGCGGAGTTCAAACAGCATTTTGCGACACAAGAAACCATTCAGTTTGGTGTGGTTTCTGACAAAGGGATGTGGCTGCATAGCCCGGTTTCTTACGCTGGGGGCGTTTTGAGTACGCTGGGCATCCAAAGCCCGCTGGCTCCATCTGAGCAAAAAGCGTATATCCCAACCAGTTTCGAACTTTTACTAAGAACCAACCCTGATTGGTTGTTAGTTGGACTTTACTCTCAACCAAATATTGTGGATGAGTGGCGCAAAAACCCATTATTTAAGCTGCTAACCGCTGCGAAAAAACAGCAACTTGTTGAGGTATCTCCTGAACTGTGGTCGTTAAATCGCGGCATGTTGGCTGCGGAAGAAATTGCCCGCAATCTTGAAGCGTTATTGGAGCGCTCATGA	MKNKKQFTIKHFSTVLLMLLSSALMSFSAFSQARSVQDEQGTFELEAIPQRIVVLEFSFVDALAAVDVSPVGVADDNDAIRVIPAVRAKIEPWQSVGMRSQPSLEAIAVLKPDLIIADAERHRAIYQDLQRIAPTLLLKSRGETYQENLESAQKIGVAIGKQAKMTQRIEQHKQTMAEFKQHFATQETIQFGVVSDKGMWLHSPVSYAGGVLSTLGIQSPLAPSEQKAYIPTSFELLLRTNPDWLLVGLYSQPNIVDEWRKNPLFKLLTAAKKQQLVEVSPELWSLNRGMLAAEEIARNLEALLERS	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	62.53	gnl|BL_ORD_ID|27|hsp_num:0	33		
BGC0000947.1|Vibrioferrin_11 # 12972 # 14009 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.522	BGC0000947.1|Vibrioferrin_11 	12972	14009	+	Loose	500	24.6386	ErmD	25.27	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGTGCGGCGATAAGCTCGGAAAGCGCGTCTTCGGTTAGCAAATCGCATTGGAAAGCGAGCTTGTTTGTCTGTGCTATGGCGTTGTGTACGCTCTCAGGCTATGCAGCCTCAATGATTGGCTGGTCCAACTTTTCTTTGAGCGTTAATGATCTGACAAGCTATTGGTTTGCGTTTGATGAGGGCAATATGCTGCATCAAATCCTCGCGACGCTGCGTGCGCCTCGTACCTATGCTGGGTTATTAATTGGCGCTTCGCTTGCGGTATCCGGAGTGCTGATGCAAGGATTGACTCGTAACCCTTTGGCGTCGCCATCCATTCTCGGCATTAATGCAGGTGCGGCGTGTTTTATGGCCTTGGCGTCCATCGGCGTACCATTCTTTAGTCAATTGAACCCAATCATCAACGCAGTACTCGGCGCGCTACTAAGTGGTGGTGCGGTCATGTTGTTGGGCGGCTTTTTCTCCGCGCGTTCTCACCCATTGCGTTTAGTGCTAGCGGGCATTGCCATCAGTGCACTGCTGATAGGGTTAACTCGTGCGTCGGTAATTTTGGCGGATGACATGGCTTACAGCGTGTTGCATTGGTTAACGGGTTCACTCTCCGCGGTAGATTCTGAGCAGTGGCAGCAACTGTGGCCTTTTGCGACTTTAGGTTTGGTGCTCGCCATGGGCTTAGCGCGAAACTTAAATTTACTCGCGTTGGGGGACGAAGTTGCTGTCGGGTTGGGTGGTAACATTCGTCTTACGCGATTAATCAGTGGTTTAGCGGTTGTGCTGTTGGCAGGAACTAGCGTAGCGACTGCTGGACCAATTGGCTTTGTCGGGTTGTTAGTGCCGCACTTGGTACGCCCGATTGTTGGTCACAACTATCACATTCTCATTCCGGTTTCCGCCTTGTGTGGCGCGGCATTGGTCACGTGGTCAGATGCTTTATCACGCGCGATTGCCTTTCCGGCTGAAACGCCAGTGGGCGTGATTACCGCGCTGTTGGGCACACCTTGCTTTATCGCGATTGCAATGAGGAAATCATCATGA	MSAAISSESASSVSKSHWKASLFVCAMALCTLSGYAASMIGWSNFSLSVNDLTSYWFAFDEGNMLHQILATLRAPRTYAGLLIGASLAVSGVLMQGLTRNPLASPSILGINAGAACFMALASIGVPFFSQLNPIINAVLGALLSGGAVMLLGGFFSARSHPLRLVLAGIAISALLIGLTRASVILADDMAYSVLHWLTGSLSAVDSEQWQQLWPFATLGLVLAMGLARNLNLLALGDEVAVGLGGNIRLTRLISGLAVVLLAGTSVATAGPIGFVGLLVPHLVRPIVGHNYHILIPVSALCGAALVTWSDALSRAIAFPAETPVGVITALLGTPCFIAIAMRKSS	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	120.21	gnl|BL_ORD_ID|1049|hsp_num:0	1117		
BGC0000947.1|Vibrioferrin_12 # 14006 # 14977 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.510	BGC0000947.1|Vibrioferrin_12 	14006	14977	+	Loose	400	25.409	IMP-35	28.79	3002226	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGATGAATCAAACCAAACTGTTTGCATTAGTTGGATTGTTGCTGATTGCGTCTTCTCTCACGCTGTTTGTTGGCGCGGCGAACATGTCGGCTCAACAGGTTTTTGCATTGCTGTTTTCTTTCTCTGACTCGGACTTTGTGATTCACCAATATCGATTACCGAGAATGTTGCTCGCCATTGGCGTGGGCGCTGGGTTGGGGCTGTCAGGCGTTTTAGTTCAAGGCGTCATCCGTAATCCACTTGCCTCACCAGATTTAATGGGGATAAGCGCCGGAGCAGGACTGGCCGCTACCGCTTGTTTGGTGCTGTATCCGAATGCGCCAGTGGCAATGTTGCCGATGGTCGCCATGGCGGGAGGCTTGCTTGCTGCTGGCTTTATTGCTGTGCTGGCTTACTGGTCGAAACCAACACCAGCACGTTTGGCGCTGATTGGTGTTGCTGTCAGCGCATTTTTAGCCAGCGGTATCGATTTTCTTCTGATTGTGCACCCTATCGAAATCAACACGGCGATGGTATGGCTAACCGGCAGTTTGTGGGGACGAAATTGGCAACAAGTGCCGTTTATTTGGAGTGCTCTATTGCTGCTACTACCATTGGCGTTTTGGCTGGCTTGGCGGCTAGATGTTATGGGACTGGGAGAAGAAAGCGCCACTACACTTGGCACGAAACCAAGACAGATCCAAATTCTTGCGTTGATTGCTGCCGTGCTATTGGCGAGTATCAGTGTGTCTGTGGCAGGCACGATCAGCTTTGTTGGCCTGCTTGCGCCGCATCTTGCGCGTTTGCTGTTTGGCCACACCCACAAGTTGTTGATTCCAGCCGCTGCAACCCTGGGCGCTTTGTTGGTGATTTGCGCCGATGGTTTAGCGAGAGGCTTACAGCCACCAATTGAGCTACCAGCGGGAGTGCTGACATCTGTTATTGGCGCACCATATTTCATTTTTCTTTTGTATCGTTATAGAGGTTGGTAA	MMNQTKLFALVGLLLIASSLTLFVGAANMSAQQVFALLFSFSDSDFVIHQYRLPRMLLAIGVGAGLGLSGVLVQGVIRNPLASPDLMGISAGAGLAATACLVLYPNAPVAMLPMVAMAGGLLAAGFIAVLAYWSKPTPARLALIGVAVSAFLASGIDFLLIVHPIEINTAMVWLTGSLWGRNWQQVPFIWSALLLLLPLAFWLAWRLDVMGLGEESATTLGTKPRQIQILALIAAVLLASISVSVAGTISFVGLLAPHLARLLFGHTHKLLIPAAATLGALLVICADGLARGLQPPIELPAGVLTSVIGAPYFIFLLYRYRGW	MKKIFVLFVFLFCSITAAGESLPDIKIEKLDEDVYVHTSFEEDNGWGVITKHGLVVLVNTDAYIIDTPFTAKDTEKLVRWFVGRGYKIKGSISSHFHSDSAGGIEWLNSQSIPTYASKLTNELLKKNGNAQAENSFSGVSYWLVKHKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFIKPDGLGYLGDANLEAWPKSAETLMSKYGNAKLVVSSHSEIGGASLLKRTWEQAVKGLKESKKPSQPNN	131.30	gnl|BL_ORD_ID|1004|hsp_num:0	1069		
BGC0000947.1|Vibrioferrin_13 # 14980 # 15744 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.477	BGC0000947.1|Vibrioferrin_13 	14980	15744	+	Loose	650	87.0409	tetA(58)	26.73	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTACGAACGCAGAACTTATCCGTCGCGTACGGCAAACAGACCATCATTCCAGATCTCTCTTTGTCGATTCCTCAAGGTAAAATTACCGCGCTTGTTGGCCCAAATGGTTGCGGTAAATCGACACTATTAAAAACCTTGGTACGCATCAATAAACCAGCTTCTGGCCAAGTGTTGTATAACGACAAGCCACTAAGCAGCTACGGTGATAAACGCTTGGCACGCTCGTTGTCTTTGCTGCCGCAAATTCTTGTCAGTCCTGAAGGTATTACAGTCAGAAAACTGGTCGAATATGGCCGCTCGCCTTATCTCTCTCACTGGGGGCGGTTAAGTCAGCAAGATAAAGCGTTGGTTGAGCAAGTAATGCAAGATACTGGCGTGATTGAGTTTGCTGACAAGCCAGTTGAATCGTTGTCTGGCGGTCAAAGGCAAAGGGCGTGGATTGCGATGGTAATGGCGCAAGATACCGACGTAGTGATGCTTGATGAGCCAACCACTTACTTGGATCTCTCTCACCAAGTTGAGCTGATGAAACTTATGAGGAAGATGAACGACAAAGGCAAAACAGTGGTCGTAGTGCTGCACGATCTAAACCAAGCCTGCCGTTACTGCGATCATTTGGTGGTGTTGGAAAAAGGTCAGTTAGTCACGCAGGGAACACCGCAAGAGGTACTGACAGAAGGTATGTTGGCATCGGTGTTTGATTTACAAGCGAGAGTATTTAACGACCCAATCTCAGGCACGCCGATGTGTGTGGCGGTGTAA	MLRTQNLSVAYGKQTIIPDLSLSIPQGKITALVGPNGCGKSTLLKTLVRINKPASGQVLYNDKPLSSYGDKRLARSLSLLPQILVSPEGITVRKLVEYGRSPYLSHWGRLSQQDKALVEQVMQDTGVIEFADKPVESLSGGQRQRAWIAMVMAQDTDVVMLDEPTTYLDLSHQVELMKLMRKMNDKGKTVVVVLHDLNQACRYCDHLVVLEKGQLVTQGTPQEVLTEGMLASVFDLQARVFNDPISGTPMCVAV	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	74.05	gnl|BL_ORD_ID|2287|hsp_num:0	2517		
BGC0000947.1|Vibrioferrin_14 # 15861 # 16121 # -1 # ID=1_14;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.494	BGC0000947.1|Vibrioferrin_14 	15861	16121	-	Loose	300	23.483	dfrA25	29.55	3003020	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GAAGATGCTGATCGCGCAGCACTGGCTCTGGATGAAATCAACGCGGCCGTTGCGCTGATCAGCGATATGGCAACGCAAATTGCGACAGCCGCCGAAGAGCAAACGCACGTAACCAATGAAATCACGCAAAACGTCACGTCCATTAAAGATGTGACCGATCACTTGGTAGTTGGTGCCGAAGAATCGATGAATCAATCTGCTGAGCTGAAATCGCAAGCTGAGGATCTCAACTCGAAAGTGGCAACGTTTAAACTGGCTTAA	EDADRAALALDEINAAVALISDMATQIATAAEEQTHVTNEITQNVTSIKDVTDHLVVGAEESMNQSAELKSQAEDLNSKVATFKLA	MAARAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGPLPNRKYAVVTRSNWTAANENVVVFPSIDEAMGRLGEITDHVIVAGGGEIYHETIPMASTLHVSTIDVEPEGDVFFPNIPGKFDVVFEQQFTSNINYCYQIWQKG	56.58	gnl|BL_ORD_ID|491|hsp_num:0	524		
